SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.2375   0.00025 (+0.11%) Volume: 58.83k 3:47 PM EDT Jul 1, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)309/30/2010
DEF 14COther definitive information statements108/11/2010
PRE 14COther preliminary information statements107/30/2010
10-QGeneral form for quarterly reports under Section 13 or 15(d)307/13/2010
10-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]306/01/2010
10-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]305/28/2010
10-QGeneral form for quarterly reports under Section 13 or 15(d)304/15/2010
10-QGeneral form for quarterly reports under Section 13 or 15(d)301/14/2010
8-KCurrent report pursuant to Section 13 or 15(d)212/01/2009
10-KAnnual report pursuant to Section 13 or 15(d)311/30/2009
10-QGeneral form for quarterly reports under Section 13 or 15(d)307/10/2009
8-K/A[Amend]Current report pursuant to Section 13 or 15(d)107/07/2009
8-KCurrent report pursuant to Section 13 or 15(d)105/27/2009
10-QGeneral form for quarterly reports under Section 13 or 15(d)304/14/2009
10-QGeneral form for quarterly reports under Section 13 or 15(d)301/13/2009
123456789101112131415